12-77831636-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024383.2(NAV3):āc.175A>Cā(p.Lys59Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001024383.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NAV3 | NM_001024383.2 | c.175A>C | p.Lys59Gln | missense_variant | 1/40 | ENST00000397909.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NAV3 | ENST00000397909.7 | c.175A>C | p.Lys59Gln | missense_variant | 1/40 | 1 | NM_001024383.2 | ||
NAV3 | ENST00000536525.6 | c.175A>C | p.Lys59Gln | missense_variant | 1/39 | 1 | P1 | ||
NAV3 | ENST00000549464.5 | c.175A>C | p.Lys59Gln | missense_variant | 1/10 | 5 | |||
NAV3 | ENST00000550042.2 | c.73-108683A>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249066Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135106
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461764Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727194
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.175A>C (p.K59Q) alteration is located in exon 1 (coding exon 1) of the NAV3 gene. This alteration results from a A to C substitution at nucleotide position 175, causing the lysine (K) at amino acid position 59 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at